Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.

Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 9, 2026, 4:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 247 matching trials from the live ClinicalTrials.gov search.
Filters: Intervention: Human Papillomavirus Vaccine Clear all
Completed No phase listed Observational

Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults

NCT04766164
View directory record Official record
Conditions
HPV Vaccine Knowledge
Interventions
Survey
Behavioral
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
Other
Eligibility
18 Years to 45 Years
Enrollment
4,000 participants
Timeline
2021 – 2022
U.S. locations
1
States / cities
Tampa, Florida
Source: ClinicalTrials.gov public record
Updated Nov 3, 2022 · Synced Oct 9, 2026, 4:41 PM EDT
Not listed Not applicable Interventional Accepts healthy volunteers

A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study

NCT01133509
View directory record Official record
Conditions
Genital Human Papilloma Virus Infection
Interventions
Gardasil
Drug
Lead sponsor
Eastern Virginia Medical School
Other
Eligibility
18 Years to 26 Years · Female only
Enrollment
100 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2009 – 2012
U.S. locations
1
States / cities
Norfolk, Virginia
Source: ClinicalTrials.gov public record
Updated Aug 23, 2012 · Synced Oct 9, 2026, 4:41 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Video to Promote HPV Vaccination

NCT02196454
View directory record Official record
Conditions
Vaccine Acceptance, Social Acceptance, Acceptance Processes, Health Behavior, Human Papillomavirus
Interventions
Educational Video with Male or Female Narrator
Other
Lead sponsor
Children's Hospital of Philadelphia
Other
Eligibility
11 Years and older
Enrollment
110 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2014 – 2018
U.S. locations
2
States / cities
Flourtown, Pennsylvania • Philadelphia, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Jun 1, 2018 · Synced Oct 9, 2026, 4:41 PM EDT
Recruiting Phase 2 Interventional

pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer

NCT05799144
View directory record Official record
Conditions
Metastatic Oropharyngeal Carcinoma, Recurrent Oropharyngeal Carcinoma
Interventions
DNA Vaccine, Human Papillomavirus Tumor Antigen Vaccine, Pembrolizumab, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Magnetic Resonance Imaging, Biopsy
Biological · Procedure
Lead sponsor
Michael K. Gibson
Other
Eligibility
18 Years and older
Enrollment
54 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2028
U.S. locations
2
States / cities
Birmingham, Alabama • Nashville, Tennessee
Source: ClinicalTrials.gov public record
Updated Jul 15, 2026 · Synced Oct 9, 2026, 4:41 PM EDT
Terminated Phase 1 Interventional

This is a Trial of MG1-E6E7 With Ad-E6E7 and Atezolizumab in Patients With HPV Associated Cancers

NCT03618953
View directory record Official record
Conditions
HPV-Associated Cancers
Interventions
Ad-E6E7, MG1-E6E7, Atezolizumab
Biological
Lead sponsor
Turnstone Biologics, Corp.
Industry
Eligibility
18 Years and older
Enrollment
8 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2018 – 2021
U.S. locations
5
States / cities
Miami, Florida • Billings, Montana • New York, New York + 2 more
Source: ClinicalTrials.gov public record
Updated Apr 14, 2023 · Synced Oct 9, 2026, 4:41 PM EDT
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US

NCT00799825
View directory record Official record
Conditions
Infections, Papillomavirus
Interventions
GSK Biological's HPV vaccine GSK580299 (Cervarix™)
Biological
Lead sponsor
GlaxoSmithKline
Industry
Eligibility
18 Years and older · Female only
Enrollment
346 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2009 – 2012
U.S. locations
39
States / cities
San Diego, California • San Francisco, California • Denver, Colorado + 34 more
Source: ClinicalTrials.gov public record
Updated Jul 12, 2018 · Synced Oct 9, 2026, 4:41 PM EDT
Active, not recruiting Phase 2 Interventional

Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia

NCT03519464
View directory record Official record
Conditions
Idiopathic CD4 T Cell Lymphocytopenia
Interventions
Gardasil 9
Biological
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Eligibility
18 Years to 70 Years
Enrollment
54 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2026
U.S. locations
1
States / cities
Bethesda, Maryland
Source: ClinicalTrials.gov public record
Updated Oct 8, 2026 · Synced Oct 9, 2026, 4:41 PM EDT
Completed No phase listed Observational Accepts healthy volunteers

Health Care Decisions for Female Adolescents: The Role of Mothers and Daughters in Decision Making

NCT00807898
View directory record Official record
Conditions
Cervical Cancer
Interventions
Not listed
Lead sponsor
University of Louisville
Other
Eligibility
13 Years and older · Female only
Enrollment
136 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2009 – 2011
U.S. locations
1
States / cities
Louisville, Kentucky
Source: ClinicalTrials.gov public record
Updated May 5, 2017 · Synced Oct 9, 2026, 4:41 PM EDT
Active, not recruiting Phase 3 Interventional Accepts healthy volunteers

PREVENT HPV -Related Cancers Trial

NCT07217145
View directory record Official record
Conditions
HPV Vaccination, Uptake Vaccination, Series Completion
Interventions
PREVENT
Behavioral
Lead sponsor
University of Utah
Other
Eligibility
18 Years and older
Enrollment
1,455 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2025 – 2027
U.S. locations
1
States / cities
Seattle, Washington
Source: ClinicalTrials.gov public record
Updated Jun 5, 2026 · Synced Oct 9, 2026, 4:41 PM EDT
Completed Phase 2 Interventional Results available

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

NCT00513526
View directory record Official record
Conditions
Infection, Precancerous Condition
Interventions
Gardasil
Biological
Lead sponsor
AIDS Malignancy Consortium
Network
Eligibility
18 Years and older · Male only
Enrollment
112 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2007 – 2011
U.S. locations
8
States / cities
Los Angeles, California • San Francisco, California • Denver, Colorado + 4 more
Source: ClinicalTrials.gov public record
Updated Nov 14, 2023 · Synced Oct 9, 2026, 4:41 PM EDT
Active, not recruiting Phase 1Phase 2 Interventional

Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers

NCT04713046
View directory record Official record
Conditions
HPV 16+ Recurrent or Metastatic Cancer
Interventions
CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16, Non-myeloablative allogeneic bone marrow transplant from related donors vaccinated against HPV16
Biological
Lead sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Other
Eligibility
18 Years and older
Enrollment
24 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2026
U.S. locations
1
States / cities
Baltimore, Maryland
Source: ClinicalTrials.gov public record
Updated Apr 2, 2026 · Synced Oct 9, 2026, 4:41 PM EDT
Completed Phase 1 Interventional

A Phase I Clinical Trial of an HPV Therapeutic Vaccine

NCT01653249
View directory record Official record
Conditions
Human Papillomavirus
Interventions
Vaccine consisting of four HPV-16 E6 peptides in combination with Candin®
Biological
Lead sponsor
University of Arkansas
Other
Eligibility
18 Years to 50 Years · Female only
Enrollment
52 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012 – 2015
U.S. locations
1
States / cities
Little Rock, Arkansas
Source: ClinicalTrials.gov public record
Updated Oct 12, 2016 · Synced Oct 9, 2026, 4:41 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Conversations With AI Chatbots Increase Short-Term Vaccine Intentions But Do Not Outperform Standard Public Health Messaging

NCT07132125
View directory record Official record
Conditions
HPV Vaccination Intent
Interventions
Default-style LLM chatbot, Conversational-style LLM chatbot, Public health informational materials
Behavioral
Lead sponsor
University of Pennsylvania
Other
Eligibility
18 Years and older
Enrollment
930 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2025
U.S. locations
1
States / cities
Philadelphia, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Aug 20, 2025 · Synced Oct 9, 2026, 4:41 PM EDT
Recruiting Not applicable Interventional

ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention

NCT06535139
View directory record Official record
Conditions
Papillomavirus Vaccines
Interventions
Brief training, Parent-targeted motivational aids, Healthcare access
Behavioral
Lead sponsor
University of Florida
Other
Eligibility
8 Years to 99 Years
Enrollment
4,630 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2027
U.S. locations
1
States / cities
Gainesville, Florida
Source: ClinicalTrials.gov public record
Updated Oct 8, 2026 · Synced Oct 9, 2026, 4:41 PM EDT
Completed No phase listed Observational Accepts healthy volunteers Results available

Adaptation Of An HPV Education Resource To Promote HPV Vaccination

NCT04974619
View directory record Official record
Conditions
HPV Vaccine, HPV
Interventions
Online survey, Focus groups or Individual Interviews, Interviews
Behavioral
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
Other
Eligibility
18 Years and older
Enrollment
155 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2021 – 2022
U.S. locations
1
States / cities
Tampa, Florida
Source: ClinicalTrials.gov public record
Updated Jun 4, 2024 · Synced Oct 9, 2026, 4:41 PM EDT
Active, not recruiting Phase 4 Interventional Accepts healthy volunteers

Immunogenicity of Fractional Dose of the HPV Vaccines

NCT05291871
View directory record Official record
Conditions
HPV Infection, HPV Vaccine
Interventions
HPV vaccine
Biological
Lead sponsor
University of Washington
Other
Eligibility
27 Years to 45 Years
Enrollment
92 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022 – 2026
U.S. locations
1
States / cities
Seattle, Washington
Source: ClinicalTrials.gov public record
Updated May 5, 2026 · Synced Oct 9, 2026, 4:41 PM EDT
Completed Not applicable Interventional

Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County

NCT02067507
View directory record Official record
Conditions
Human Papilloma Virus Infection
Interventions
Tailored education and referral, Staff training and patient reminders, Clinic-level reminder systems
Behavioral
Lead sponsor
University of California, Los Angeles
Other
Eligibility
9 Years to 70 Years
Enrollment
53,414 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012 – 2019
U.S. locations
2
States / cities
Alhambra, California • San Fernando, California
Source: ClinicalTrials.gov public record
Updated Oct 25, 2019 · Synced Oct 9, 2026, 4:41 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates

NCT01526551
View directory record Official record
Conditions
Human Papillomavirus
Interventions
HPV Vaccine and HPV-related Health Education, Reduction of barriers
Other
Lead sponsor
Lake Cumberland District Health Department
Other
Eligibility
12 Years to 20 Years
Enrollment
935 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2012 – 2013
U.S. locations
2
States / cities
Monticello, Kentucky
Source: ClinicalTrials.gov public record
Updated Mar 6, 2015 · Synced Oct 9, 2026, 4:41 PM EDT
Recruiting Not applicable Interventional

PCOM2 - The Physician Communication Intervention, Version 2.0

NCT05336240
View directory record Official record
Conditions
HPV Infection, Preventive Health Services
Interventions
Physician Communication 2 Virtual (PCOM2-virtual), Physician Communication Standard (PCOM-standard)
Behavioral
Lead sponsor
University of Colorado, Denver
Other
Eligibility
9 Years to 17 Years
Enrollment
120 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2026
U.S. locations
2
States / cities
Aurora, Colorado • Wichita, Kansas
Source: ClinicalTrials.gov public record
Updated Aug 26, 2024 · Synced Oct 9, 2026, 4:41 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

A Multilevel Approach to Increasing HPV Vaccine Initiation Among Adolescents - Part 3

NCT04208269
View directory record Official record
Conditions
Human Papilloma Virus
Interventions
postcard campaign, Health Information Technology system
Other
Lead sponsor
University of Florida
Other
Eligibility
11 Years to 18 Years
Enrollment
5,663 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2013 – 2015
U.S. locations
1
States / cities
Gainesville, Florida
Source: ClinicalTrials.gov public record
Updated May 19, 2020 · Synced Oct 9, 2026, 4:41 PM EDT
Completed No phase listed Observational Accepts healthy volunteers

Immunogenicity of Off-Schedule Dosing of HPV Vaccine

NCT01030562
View directory record Official record
Conditions
Papilloma Viral Infection
Interventions
Not listed
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Eligibility
9 Years to 17 Years · Female only
Enrollment
1,321 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2010 – 2014
U.S. locations
7
States / cities
Tucker, Georgia • Baltimore, Maryland • Kansas City, Missouri + 4 more
Source: ClinicalTrials.gov public record
Updated Oct 29, 2018 · Synced Oct 9, 2026, 4:41 PM EDT
Completed No phase listed Observational Accepts healthy volunteers

Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting

NCT00828555
View directory record Official record
Conditions
Influenza Vaccine, Papillomavirus Infection, Pertussis
Interventions
Vaccination Program
Other
Lead sponsor
Duke University
Other
Eligibility
12 Years to 26 Years · Female only
Enrollment
3,988 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2008 – 2012
U.S. locations
4
States / cities
Burlington, North Carolina • Durham, North Carolina • Raleigh, North Carolina
Source: ClinicalTrials.gov public record
Updated Oct 16, 2012 · Synced Oct 9, 2026, 4:41 PM EDT
Completed Not applicable Interventional

Optimizing Application And Support Of Immunization Information Systems (OASIS)

NCT02010372
View directory record Official record
Conditions
Increase in Use of Immunization Registry, Increase in HPV Vaccination Rate
Interventions
Reminder Recall Report, Audit-Feedback/Immunization Forecasting Reports
Other
Lead sponsor
University of Rochester
Other
Eligibility
Not listed
Enrollment
31 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2015
U.S. locations
1
States / cities
Rochester, New York
Source: ClinicalTrials.gov public record
Updated Feb 25, 2016 · Synced Oct 9, 2026, 4:41 PM EDT
Completed Phase 3 Interventional Results available

Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects

NCT00937950
View directory record Official record
Conditions
Infections, Papillomavirus
Interventions
Gynaecological follow-up
Other
Lead sponsor
GlaxoSmithKline
Industry
Eligibility
18 Years and older · Female only
Enrollment
2,022 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2014
U.S. locations
18
States / cities
Clearwater, Florida • Miami, Florida • Honolulu, Hawaii + 14 more
Source: ClinicalTrials.gov public record
Updated Oct 29, 2019 · Synced Oct 9, 2026, 4:41 PM EDT